Intravacc enrols first subject in intranasal Covid-19 booster trial – Clinical Trials Arena

The initial interim data from the trial is anticipated by the end of the first quarter of next year.Intravacc has enrolled the first subject in a Phase I clinical trial analysing its intranasal subunit vaccine for Covid-19, Avacc 10, as a booster.The double-blind, randomised, placebo and outer membrane vesicles (OMV ) controlled, first-in-human trial was launched at […]

Continue reading

COVID-19 disruptions in HIV testing and prevention highlight need for innovation and investment before the next public health emergency | CDC Online Newsroom – CDC

For Immediate Release: Thursday, December 1, 2022 Contact: Media Relations (404) 639-3286The nation’s ability to prevent HIV was dealt a hard blow early in the COVID-19 pandemic, according to a new CDC analysis published today, on World AIDS Day: Putting Ourselves to the Test: Achieving Equity to End HIV. A rapid rebound in services, however, […]

Continue reading
1 207 208 209 210 211 245